Diabetic Gastroparesis Treatment Market Global Size

Global Market Study on Diabetic Gastroparesis
Treatment: Drugs Products Type Segment
Expected for Account for Maximum Revenue
Share by 2024

P e r s i s t e n c e M a r k e t R e s e a r c h
Report Media Releases
Global Diabetic Gastroparesis Treatment Market to be
Valued at US$ 3,769.3 Mn by 2024; Rising demand for
Antiemetic Agents expected to Boost Market Growth
According to the latest market report published by Persistence Market Research titled “Diabetic
Gastroparesis Treatment Market: Global Industry Analysis and Forecast, 2016 – 2024”, revenue
from the global diabetic gastroparesis treatment market is projected to register a CAGR of 4.1%
during the forecast period (2016–2024). Diabetic gastroparesis is the symptom of delayed gastric
emptying affecting patients suffering from Type-1 and Type-2 diabetes. The disease primarily
has no cure but its symptoms are treatable via various types of drugs and devices. The global
diabetic gastroparesis treatment market was valued at US$ 2,650 Mn in 2015, which is expected
to increase to US$ 3,769.3 Mn by 2024. The report analyzes the global diabetic gastroparesis
treatment market in terms of market value on the basis of product type, disease indication, and
distribution channel; and provides information regarding regional market dynamics, regulations,
current trends, market estimations, and forecast.
Browse Complete Research Here @ http://www.persistencemarketresearch.com/marketresearch/diabetic-gastroparesis-market.asp
Rising prevalence of Type-1 and Type-2 diabetes with high unmet medical needs, growing
demand for minimally invasive treatment for refractory gastroparesis, and availability of
reimbursement for in-patient hospital stays are driving growth of the global diabetic gastroparesis
treatment market. Increasing use of diabetic gastroparesis drugs to control symptoms such as
nausea and vomiting is anticipated to fuel growth of the global diabetic gastroparesis treatment
market over the forecast period. However, usage of non-prescription drugs to control the
symptoms restricts diagnosis of stage 1 and stage 2 gastroparesis. Lack of clinical evidence on
improvement offered by prescription drugs and termination of clinical trials are factors expected
to hamper growth of the global diabetic gastroparesis treatment market over the forecast period.
Request for Table of Content Here @ http://www.persistencemarketresearch.com/marketresearch/diabetic-gastroparesis-market/toc
The global diabetic gastroparesis treatment market has been segmented on the basis of product
type into drugs and surgical treatment products; on the basis of disease indication into
compensated gastroparesis and gastric failure; and on the basis of distribution channel into
Global Diabetic Gastroparesis Treatment 2016-2024

P e r s i s t e n c e M a r k e t R e s e a r c h
hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce. Among
product types, the drugs segment dominated the market with maximum revenue share of 66% in
2015 followed by the surgical treatment product segment with 34% share. Enhanced
development of novel products such as the domperidone drug for the treatment of gastric motility
disorder are expected to fuel the growth of the drugs segment over the forecast period. The
hospital pharmacies segment is estimated to account for the highest market revenue share of
48.0% in the global diabetic gastroparesis treatment market by the end of 2016.
The report covers the global diabetic gastroparesis treatment market across five key regions
namely North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa
(MEA). North America is expected to remain the dominant market throughout the forecast period,
driven by rise in healthcare expenditure, increasing demand for metoclopramide agents in the
management of diabetic gastroparesis disease, increasing research on antibodies and other
innovative prokinetics drug delivery formats, and technological advancements. Revenue from the
diabetic gastroparesis treatment market in North America is expected to register a CAGR of
4.4% over the forecast period. Asia Pacific is expected to remain the second-most lucrative
market for diabetic gastroparesis treatment, with an estimated CAGR of 4.5% over the forecast
period.
Download Research Study Here @
http://www.persistencemarketresearch.com/samples/10082
Some of the top companies profiled in the report are Janssen Global Services, LLC, Salix
Pharmaceuticals, Inc., Abbott Laboratories, Medtronic, C. R. Bard, Inc., Kimberly-Clark
Corporation, Boston Scientific Corporation, Cardinal Health, Inc., Rhythm Pharmaceuticals, Inc.,
Evoke Pharma, and Alfa Wassermann SPA. Leading market players are continuously
introducing novel products to enhance their product portfolio, increase market share, and expand
customer base.
Global Diabetic Gastroparesis Treatment 2016-2024

P e r s i s t e n c e M a r k e t R e s e a r c h
About Us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Our offerings include pre-built reports that address every major sale, customized solutions to
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration
research approach for exploring emerging technologies has allowed us to solve the
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and
provide the latest insights into these technologies when they are being commercialized. Our
ground-breaking approach allows us to deliver market solutions before the technologies reach
the market.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing
startups. PMR’s collaborative environment is committed to building industry-specific solutions by
transforming data from multiple streams into a strategic asset.
Contact Us:
Persistence Market Research
90 Sate Street, Suite 700 Albany, NY 12207
Tel: +1-518-618-1030
Email: sales@persistencemarketresearch.com
Website: http://www.persistencemarketresearch.com/
media@persistencemarketresearch.com
Stay updated with our official Blog: http://pmrblog.com
Global Diabetic Gastroparesis Treatment 2016-2024